Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26952546

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2016 May 7
First author
Rosenberg JE

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 May 7;387(10031):1881-2. doi: 10.1016/S0140-6736(16)00654-1.
    note
    Source null
    related pmid
    26952549
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2016 May;13(5):266. doi: 10.1038/nrclinonc.2016.48.
    note
    Source null
    related pmid
    27000959
    relationship
    Comment in
  3. citation
    Nat Rev Urol. 2016 May;13(5):238. doi: 10.1038/nrurol.2016.60.
    note
    Source null
    related pmid
    27001012
    relationship
    Comment in
  4. citation
    Eur Urol. 2017 Feb;71(2):299-300. doi: 10.1016/j.eururo.2016.10.012.
    note
    Source null
    related pmid
    27780644
    relationship
    Comment in
  5. citation
    J Urol. 2016 Dec;196(6):1637-1638. doi: 10.1016/j.juro.2016.09.025.
    note
    Source null
    related pmid
    27845104
    relationship
    Comment in
  6. citation
    Lancet. 2018 Jan 27;391(10118):305-306. doi: 10.1016/S0140-6736(18)30095-3.
    note
    Source null
    related pmid
    29413038
    relationship
    Comment in

Authors and identifiers

  1. name
    Rosenberg JE
    type
    Author
  2. name
    Hoffman-Censits J
    type
    Author
  3. name
    Powles T
    type
    Author
  4. name
    van der Heijden MS
    type
    Author
  5. name
    Balar AV
    type
    Author
  6. name
    Necchi A
    type
    Author
  7. name
    Dawson N
    type
    Author
  8. name
    O'Donnell PH
    type
    Author
  9. name
    Balmanoukian A
    type
    Author
  10. name
    Loriot Y
    type
    Author
  11. name
    Srinivas S
    type
    Author
  12. name
    Retz MM
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Rosenberg JE
    type
    Author
  2. name
    Hoffman-Censits J
    type
    Author
  3. name
    Powles T
    type
    Author
  4. name
    van der Heijden MS
    type
    Author
  5. name
    Balar AV
    type
    Author
  6. name
    Necchi A
    type
    Author
  7. name
    Dawson N
    type
    Author
  8. name
    O'Donnell PH
    type
    Author
  9. name
    Balmanoukian A
    type
    Author
  10. name
    Loriot Y
    type
    Author
  11. name
    Srinivas S
    type
    Author
  12. name
    Retz MM
    type
    Author
bibliography ids
  1. nci-bib-d68bce481d001c94cd379fa6
book metadata
content sha256
04b25ac9f6148fd5a142eff5a002bdd852fc0ce355370a9d320e5623f7f3e34f
document type
citation
dois
  1. 10.1016/S0140-6736(16)00561-4
electronic publication date
display
2016 Mar 4
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:26952546
immutable id
pubmed:26952546@04b25ac9f6148fd5a142eff5a002bdd852fc0ce355370a9d320e5623f7f3e34f
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10031
name
Lancet (London, England)
nlm unique id
2985213R
pages
1909-20
volume
387
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 May 7;387(10031):1881-2. doi: 10.1016/S0140-6736(16)00654-1.
    note
    Source null
    related pmid
    26952549
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2016 May;13(5):266. doi: 10.1038/nrclinonc.2016.48.
    note
    Source null
    related pmid
    27000959
    relationship
    Comment in
  3. citation
    Nat Rev Urol. 2016 May;13(5):238. doi: 10.1038/nrurol.2016.60.
    note
    Source null
    related pmid
    27001012
    relationship
    Comment in
  4. citation
    Eur Urol. 2017 Feb;71(2):299-300. doi: 10.1016/j.eururo.2016.10.012.
    note
    Source null
    related pmid
    27780644
    relationship
    Comment in
  5. citation
    J Urol. 2016 Dec;196(6):1637-1638. doi: 10.1016/j.juro.2016.09.025.
    note
    Source null
    related pmid
    27845104
    relationship
    Comment in
  6. citation
    Lancet. 2018 Jan 27;391(10118):305-306. doi: 10.1016/S0140-6736(18)30095-3.
    note
    Source null
    related pmid
    29413038
    relationship
    Comment in
outcomes validated
false
pmid
26952546
provenance
batch id
fe5a46c92522c34737e8
provider
NCBI PubMed ESummary
record sha256
6683d990c11488fd882efe6e67a2bd16f824f1c3b4302941bea6afcada4d0422
response sha256
2c7bacd02d2ece3813daf1a0f92260c22884bd9268942fcca2088ab229bfb4d1
retrieved at
2026-09-09T23:47:17.939307+00:00
publication date
display
2016 May 7
precision
day
year
2016
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, N.I.H., Extramural
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26952546/
title
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.

Preserved source evidence · Not medical advice